BACKGROUND. In contrast to the established relation between overt cancer and subsequent venous thromboembolism, it is unclear whether symptomatic deep-vein thrombosis is associated with a risk of subsequent overt malignant disease. METHODS. Two hundred sixty consecutive patients with symptomatic, venographically proved deep-vein thrombosis were enrolled in a study, of whom 250 were followed during a two-year period. Among those assessed during follow-up, the incidence of subsequently detected cancer in the 105 patients with secondary venous thrombosis (i.e., thrombosis associated with a well-recognized risk factor other than cancer) was compared with the incidence of cancer in the 145 patients with idiopathic venous thrombosis. RESULTS. Routine examination at the time of diagnosis of the venous thrombosis revealed cancer in 5 of the 153 enrolled patients with idiopathic venous thrombosis (3.3 percent) and in none of the 107 enrolled patients with secondary venous thrombosis. During follow-up, overt cancer developed in 2 of the 105 patients with secondary venous thrombosis (1.9 percent) and in 11 of the 145 patients with idiopathic venous thrombosis (7.6 percent; odds ratio, 2.3; 95 percent confidence interval, 1.0 to 5.2; P = 0.043). Of the 145 patients with idiopathic venous thrombosis, 35 had confirmed recurrent thromboembolism. Overt cancer subsequently developed in 6 of the 35 (17.1 percent). The incidence of cancer in the patients with recurrent idiopathic venous thrombosis was higher than that in the patients with secondary venous thrombosis (P = 0.008; odds ratio, 9.8; 95 percent confidence interval, 1.8 to 52.2) or in the patients with idiopathic venous thrombosis that did not recur (P = 0.024; odds ratio, 4.3; 95 percent confidence interval, 1.2 to 15.3). CONCLUSIONS. There is a statistically significant and clinically important association between idiopathic venous thrombosis and the subsequent development of clinically overt cancer, especially among patients in whom venous thromboembolism recurs during follow-up.
Source Information
Second Department of Internal Medicine, University Hospital of Padua, Italy.
This article has been cited by other articles:
Zangari, M., Fink, L. M., Elice, F., Zhan, F., Adcock, D. M., Tricot, G. J.
(2009). Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents. JCO
27: 4865-4873
[Abstract][Full Text]
Khorana, A. A., Streiff, M. B., Farge, D., Mandala, M., Debourdeau, P., Cajfinger, F., Marty, M., Falanga, A., Lyman, G. H.
(2009). Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action. JCO
27: 4919-4926
[Abstract][Full Text]
Kuderer, N. M., Ortel, T. L., Francis, C. W.
(2009). Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival. JCO
27: 4902-4911
[Abstract][Full Text]
Boccaccio, C., Comoglio, P. M.
(2009). Genetic Link Between Cancer and Thrombosis. JCO
27: 4827-4833
[Abstract][Full Text]
Lyman, G. H., Khorana, A. A.
(2009). Cancer, Clots and Consensus: New Understanding of an Old Problem. JCO
27: 4821-4826
[Full Text]
Thomas, G. M., Panicot-Dubois, L., Lacroix, R., Dignat-George, F., Lombardo, D., Dubois, C.
(2009). Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. JEM
206: 1913-1927
[Abstract][Full Text]
BABU, B., CARMAN, T. L.
(2009). Cancer and clots: All cases of venous thromboembolism are not treated the same. Cleveland Clinic Journal of Medicine
76: 129-135
[Abstract][Full Text]
Casella, I. B., Bosch, M. A., Sabbag, C. RD.
(2009). Incidence and Risk Factors for Bilateral Deep Venous Thrombosis of the Lower Limbs. ANGIOLOGY
60: 99-103
[Abstract]
Carrier, M., Le Gal, G., Wells, P. S., Fergusson, D., Ramsay, T., Rodger, M. A.
(2008). Systematic Review: The Trousseau Syndrome Revisited: Should We Screen Extensively for Cancer in Patients with Venous Thromboembolism?. ANN INTERN MED
149: 323-333
[Abstract][Full Text]
Dalal, P U
(2008). Non-metastatic manifestations of cancer in the chest. Imaging
20: 194-204
[Abstract][Full Text]
Gross, C. M., Posch, M. G., Geier, C., Olthoff, H., Kramer, J., Dechend, R., Dietz, R., Ozcelik, C.
(2008). Subacute Coronary Stent Thrombosis in Cancer Patients. J Am Coll Cardiol
51: 1232-1233
[Full Text]
Imberti, D., Agnelli, G., Ageno, W., Moia, M., Palareti, G., Pistelli, R., Rossi, R., Verso, M., for the MASTER Investigators,
(2008). Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry. haematol
93: 273-278
[Abstract][Full Text]
Fennerty, A
(2006). Venous thromboembolic disease and cancer.. Postgrad. Med. J.
82: 642-648
[Abstract][Full Text]
Robinson, G. V
(2006). Pulmonary embolism in hospital practice. BMJ
332: 156-160
[Full Text]
Morris, D. R., Ding, Y., Ricks, T. K., Gullapalli, A., Wolfe, B. L., Trejo, J.
(2006). Protease-Activated Receptor-2 Is Essential for Factor VIIa and Xa-Induced Signaling, Migration, and Invasion of Breast Cancer Cells. Cancer Res.
66: 307-314
[Abstract][Full Text]
Lee, A. Y. Y.
(2006). Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological Mechanisms. ASH Education Book
2006: 438-443
[Abstract][Full Text]
White, R. H., Chew, H. K., Zhou, H., Parikh-Patel, A., Harris, D., Harvey, D., Wun, T.
(2005). Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528 693 Adults. Arch Intern Med
165: 1782-1787
[Abstract][Full Text]
Falanga, A., Zacharski, L.
(2005). Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol
16: 696-701
[Abstract][Full Text]
Batsis, J. A., Morgenthaler, T. I.
(2005). Trousseau Syndrome and the Unknown Cancer: Use of Positron Emission Tomographic Imaging in a Patient With a Paraneoplastic Syndrome. Mayo Clin Proc.
80: 537-540
[Abstract]
Wittkowsky, A. K.
(2004). Anticoagulation in Hypercoagulable Conditions: Special Considerations in the Treatment and Prevention of Venous Thromboembolism. Journal of Pharmacy Practice
17: 308-316
[Abstract]
Kearon, C.
(2004). Long-Term Management of Patients After Venous Thromboembolism. Circulation
110: I-10-I-18
[Abstract][Full Text]
Elting, L. S., Escalante, C. P., Cooksley, C., Avritscher, E. B. C., Kurtin, D., Hamblin, L., Khosla, S. G., Rivera, E.
(2004). Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer. Arch Intern Med
164: 1653-1661
[Abstract][Full Text]
Bates, S. M., Ginsberg, J. S.
(2004). Treatment of Deep-Vein Thrombosis. NEJM
351: 268-277
[Full Text]
Goldenberg, N., Kahn, S. R., Solymoss, S.
(2003). Markers of Coagulation and Angiogenesis in Cancer-Associated Venous Thromboembolism. JCO
21: 4194-4199
[Abstract][Full Text]
Frazee, L. A, Chomo, D. L
(2003). Duration of Anticoagulant Therapy After Initial Idiopathic Venous Thromboembolism. The Annals of Pharmacotherapy
37: 1489-1496
[Abstract][Full Text]
Kakkar, A. K., Levine, M., Pinedo, H.M., Wolff, R., Wong, J.
(2003). Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey. The Oncologist
8: 381-388
[Abstract][Full Text]
Lee, A. Y.Y., Levine, M. N.
(2003). Venous Thromboembolism and Cancer: Risks and Outcomes. Circulation
107: I-17-21
[Abstract][Full Text]
van Dongen, C. J. J., Vink, R., Hutten, B. A., Buller, H. R., Prins, M. H.
(2003). The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis. Arch Intern Med
163: 1285-1293
[Abstract][Full Text]
(2003). British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax
58: 470-483
[Full Text]
Prandoni, P., Bilora, F., Marchiori, A., Bernardi, E., Petrobelli, F., Lensing, A. W.A., Prins, M. H., Girolami, A.
(2003). An Association between Atherosclerosis and Venous Thrombosis. NEJM
348: 1435-1441
[Abstract][Full Text]
Deitcher, S. R, Gomes, M. P.
(2003). Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med
8: 33-46
[Abstract]
Naschitz, J. E., Kovaleva, J., Shaviv, N., Rennert, G., Yeshurun, D.
(2003). Vascular Disorders Preceding Diagnosis of Cancer: Distinguishing the Causal Relationship based on Bradford-Hill Guidelines. ANGIOLOGY
54: 11-17
[Abstract]
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., Girolami, A.
(2002). Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood
100: 3484-3488
[Abstract][Full Text]
Samuels, M. A., King, M. E., Balis, U.
(2002). Case 31-2002 - A 61-Year-Old Man with Headache and Multiple Infarcts. NEJM
347: 1187-1194
[Full Text]
Sheikh, M. A, Topoulos, A. P, Deitcher, S. R
(2002). Isolated internal jugular vein thrombosis: risk factors and natural history. Vasc Med
7: 177-179
[Abstract]
Zangari, M., Siegel, E., Barlogie, B., Anaissie, E., Saghafifar, F., Fassas, A., Morris, C., Fink, L., Tricot, G.
(2002). Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy. Blood
100: 1168-1171
[Abstract][Full Text]
Baarslag, H.-J., van Beek, E. J.R., Koopman, M. M.W., Reekers, J. A.
(2002). Prospective Study of Color Duplex Ultrasonography Compared with Contrast Venography in Patients Suspected of Having Deep Venous Thrombosis of the Upper Extremities. ANN INTERN MED
136: 865-872
[Abstract][Full Text]
Girolami, A.
(2001). Idiopathic Deep Vein Thrombosis and Subsequent Cancer: Suggestions for a Patient-Oriented and Practical Approach. CLIN APPL THROMB HEMOST
7: 321-324
[Abstract]
Fennerty, T.
(2001). Screening for cancer in venous thromboembolic disease. BMJ
323: 704-705
[Full Text]
Zangari, M., Anaissie, E., Barlogie, B., Badros, A., Desikan, R., Gopal, A. V., Morris, C., Toor, A., Siegel, E., Fink, L., Tricot, G.
(2001). Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood
98: 1614-1615
[Abstract][Full Text]
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., Boissel, J.-P.
(2001). Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis. Circulation
103: 2453-2460
[Abstract][Full Text]
Sorensen, H. T., Mellemkjar, L., Olsen, J. H., Baron, J. A.
(2000). Prognosis of Cancers Associated with Venous Thromboembolism. NEJM
343: 1846-1850
[Abstract][Full Text]
Brill-Edwards, P., Ginsberg, J. S., Gent, M., Hirsh, J., Burrows, R., Kearon, C., Geerts, W., Kovacs, M., Weitz, J. I., Robinson, K. S., Whittom, R., Couture, G., The Recurrence of Clot in This Pregnancy Study Gro,
(2000). Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism. NEJM
343: 1439-1444
[Abstract][Full Text]
Bauer, K. A.
(2000). Venous Thromboembolism in Malignancy. JCO
18: 3065-3067
[Full Text]
(2000). Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J
21: 1301-1336
Schulman, S., Lindmarker, P., The Duration of Anticoagulation Trial,
(2000). Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism. NEJM
342: 1953-1958
[Abstract][Full Text]
Langman, L. J., Ray, J. G., Evrovski, J., Yeo, E., Cole, D. E.C.
(2000). Hyperhomocyst(e)inemia and the Increased Risk of Venous Thromboembolism: More Evidence From a Case-Control Study. Arch Intern Med
160: 961-964
[Abstract][Full Text]
Hansson, P.-O., Sorbo, J., Eriksson, H.
(2000). Recurrent Venous Thromboembolism After Deep Vein Thrombosis: Incidence and Risk Factors. Arch Intern Med
160: 769-774
[Abstract][Full Text]
Cornuz, J., Pearson, S. D., Polak, J. F.
(1999). Deep Venous Thrombosis: Complete Lower Extremity Venous US Evaluation in Patients without Known Risk Factors—Outcome Study. Radiology
211: 637-641
[Abstract][Full Text]
Fraser, J. D., Anderson, D. R.
(1999). Deep Venous Thrombosis: Recent Advances and Optimal Investigation with US. Radiology
211: 9-24
[Full Text]
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., MacKinnon, B., Julian, J. A., Johnston, M., Douketis, J., Roberts, R., van Nguyen, P., Kassis, J., Dolan, S., Demers, C., Desjardins, L., Solymoss, S., Trowbridge, A.
(1999). A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism. NEJM
340: 901-907
[Abstract][Full Text]
Ferrari, E., Chevallier, T., Chapelier, A., Baudouy, M.
(1999). Travel as a Risk Factor for Venous Thromboembolic Disease: A Case-Control Study. Chest
115: 440-444
[Abstract][Full Text]
Kroger, K., Fischer, A., Hinrichs, A., Gocke, C., Rudofsky, G.
(1998). Patients with a Malignant Tumor Have More Extended Thrombosis Than Patients Without. ANGIOLOGY
49: 923-928
[Abstract]
Goldhaber, S. Z.
(1998). Pulmonary Embolism. NEJM
339: 93-104
[Full Text]
Heilmann, L., Tempelhoff, G.-F. V., Schneider, D.
(1998). State-of the-Art Review : Prevention of Thrombosis in Gynecologic Malignancy. CLIN APPL THROMB HEMOST
4: 153-159
Sorensen, H. T., Mellemkjar, L., Steffensen, F. H., Olsen, J. H., Nielsen, G. L.
(1998). The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism. NEJM
338: 1169-1173
[Abstract][Full Text]
Buller, H. R, Kraaijenhagen, R. A, Koopman, M. M.
(1998). Early discharge strategies following venous thrombosis. Vasc Med
3: 47-50
[Abstract]
Prandoni, P., Lensing, A. W., Prins, M. R
(1998). Long-term outcomes after deep venous thrombosis of the lower extremities. Vasc Med
3: 57-60
[Abstract]
Ridker, P. M, PREVENT Investigators,
(1998). Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Vasc Med
3: 67-73
[Abstract]
Robbins, P., Forrest, M., Royston, D.
(1997). Hypercoagulable States. SEMIN CARDIOTHORAC VASC ANESTH
1: 295-318
[Abstract]
Hirsh, J., Kearon, C., Ginsberg, J.
(1997). Duration of Anticoagulant Therapy After First Episode of Venous Thrombosis in Patients With Inherited Thrombophilia. Arch Intern Med
157: 2174-2177
[Abstract]
Douketis, J. D., Ginsberg, J. S., Holbrook, A., Crowther, M., Duku, E. K., Burrows, R. F.
(1997). A Reevaluation of the Risk for Venous Thromboembolism With the Use of Oral Contraceptives and Hormone Replacement Therapy. Arch Intern Med
157: 1522-1530
[Abstract]
Ginsberg, J. S.
(1996). Management of Venous Thromboembolism. NEJM
335: 1816-1829
[Full Text]
Hirsh, J., Hoak, J.
(1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation
93: 2212-2245
[Full Text]
Koopman, M. M.W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P.M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., Bossuyt, P. M.M., de Haes, H., van den Belt, A. G.M., Sagnard, L., d'Azemar, P., Buller, H. R., The Tasman Study Group,
(1996). Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home. NEJM
334: 682-687
[Abstract][Full Text]
Ahmed, Z., Mohyuddin, Z.
(1996). Deep Vein Thrombosis as a Predictor of Cancer. ANGIOLOGY
47: 261-265
[Abstract]
Ridker, P. M., Miletich, J. P., Stampfer, M. J., Goldhaber, S. Z., Lindpaintner, K., Hennekens, C. H.
(1995). Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism. Circulation
92: 2800-2802
[Abstract][Full Text]
Hirsh, J.
(1995). The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis. NEJM
332: 1710-1712
[Full Text]
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., Miletich, J. P.
(1995). Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men. NEJM
332: 912-917
[Abstract][Full Text]
Scitz, R., Rappe, N., Wolf, M., Heidtmann, H.-H., Maasberg, M., Immel, A., Kraus, M., Egbring, R., Pfab, R., Havemann, K.
(1995). Impaires Anticoagulant Activity of Protein C and Activation of Neutrophils in Extensive Lung Cancer. CLIN APPL THROMB HEMOST
1: 131-134
[Abstract]
Leizorovicz, A, Simonneau, G, Decousus, H, Boissel, J P
(1994). Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ
309: 299-304
[Abstract][Full Text]
(1994). Idiopathic Deep Venous Thrombosis: Is a Search for Malignant Disease Justified?. Arch Intern Med
154: 1310-1312
[Abstract]
Nordstrom, M, Lindblad, B, Anderson, H, Bergqvist, D, Kjellstrom, T
(1994). Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ
308: 891-894
[Abstract][Full Text]
Hastings, G. E., Seery, D. S., Vine, D. L.
(1993). Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism. Arch Fam Med
2: 655-669
[Abstract]
Siegelman, E. S., Needleman, L., Anderson, J. R., Roberson, P. K., Epstein, B. H., Kankaria, A., O'Connor, N., Silverstein, R. L., Nachman, R. L., Silverstein, R. L., Nachman, R. L.
(1993). Venous Thrombosis and Cancer. NEJM
328: 885-887
[Full Text]
(1992). DEEP-VEIN THROMBOSIS MAY SIGNAL UNDIAGNOSED MALIGNANCY. JWatch General
1992: 2-2
[Full Text]
Previous
